NCT07326384

Brief Summary

The goal of this observational study is to learn about the relationship between cardiac intervention and subsequent psychiatric symptoms in patients with CHD. Due to the known high prevalence of mental health issues-with up to 50% of adults and 35% of pediatric patients with CHD experiencing mood or anxiety disorders-this research is crucial for improving long-term psychosocial care. The main questions it aims to answer are:

  • What is the prevalence of psychiatric problems in CHD patients?
  • Do psychiatric problems change or evolve after a cardiac intervention?
  • Who Can Take Part (Supporting Information) The study is actively recruiting patients who meet specific criteria:
  • Diagnosed with CHD and scheduled for a palliative or corrective cardiac intervention (surgical or catheter-based).
  • Patients of both genders can participate. Patients cannot take part if they have:
  • A current or pre-existing psychiatric or neurological disorder. - How the Research Will Happen This is a prospective, longitudinal cohort study that tracks the same participants over time. Participants will be asked to complete a series of validated psychological and cognitive assessments at three specific time points:
  • T0 (Baseline): Before the cardiac procedure.
  • T1 (Short-term): Approximately 1 month after the procedure.
  • T2 (Long-term): Approximately 3 months after the procedure. Participants will complete standardized measures covering a wide range of topics, including:
  • Psychological symptoms (e.g., depression, anxiety).
  • Cognitive function (e.g., memory and attention).
  • Sleep quality.
  • Eating attitudes.
  • Suicidal ideation. Potential Benefits: This research is critical for identifying dynamic changes in mental health related to cardiac procedures and will help the medical community understand the psychological impact of these interventions, leading to better screening and long-term quality of life.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
31mo left

Started Jan 2026

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Jan 2026Nov 2028

First Submitted

Initial submission to the registry

September 30, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 8, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2028

Last Updated

January 8, 2026

Status Verified

December 1, 2025

Enrollment Period

1.8 years

First QC Date

September 30, 2025

Last Update Submit

December 24, 2025

Conditions

Keywords

Congenital heart diseasePsychiatric problemsMental health and cardiovascular diseaseCardiac intervention

Outcome Measures

Primary Outcomes (2)

  • Prevalence of psychiatric disorders in adults with congenital heart disease, as assessed by the Symptom Checklist-90-Revised (SCL-90-R) Global Severity Index.

    * Measurement Tool: Symptom Checklist-90-Revised (SCL-90-R). * Unit of Measure: Units on a Scale (Global Severity Index T-score).

    At baseline, Pre-procedure visit (within 4 weeks of intervention).

  • Prevalence of psychiatric disorders in children with congenital heart disease, as assessed by the Child Behavior Checklist (CBCL) Total Problems T-score.

    * Measurement Tool: Child Behavior Checklist (CBCL). * Unit of Measure: Units on a Scale (Total Problems T-score).

    At baseline, pre-procedure visit (within 4 weeks of intervention).

Study Arms (2)

Adult

Procedure: Cardiac interventions

Child

Procedure: Cardiac interventions

Interventions

surgical or catheter-based, Corrective or palliative.

AdultChild

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with congenital heart disease presenting for palliative or corrective cardiac intervention (surgical or catheter-based).

You may qualify if:

  • patients of both gender.
  • Confirmed diagnosis of congenital heart disease requiring surgical or catheter-based intervention.

You may not qualify if:

  • current or a pre-existing psychiatric or neurological disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart Defects, CongenitalPsychological Well-BeingCardiovascular Diseases

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPersonal SatisfactionBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Cardiology resident at Assiut University Heart Hospital

Study Record Dates

First Submitted

September 30, 2025

First Posted

January 8, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

November 1, 2028

Last Updated

January 8, 2026

Record last verified: 2025-12